Stada And Alvotech Launch Higher-Strength Adalimumab In Europe
Hukyndra Biosimilar To Humira Introduced In France, Germany, Finland And Sweden
Stada and Alvotech have announced the launch of the Hukyndra higher-strength adalimumab biosimilar rival to Humira in selected European countries, with a wider roll-out to follow in the coming months.
